The skinny on GLP-1 weight loss plans!

RenIVate is excited to announce that they offer Semaglutide and Tirzepatide! 

GLP-1 (glucagon-like peptide-1) is a hormone that plays several roles in the body, especially in regulating blood sugar and appetite. There are a few GLP-1 receptor agonists, which are synthetic versions of this hormone, used in medical treatments, especially for managing type 2 diabetes and obesity. 

GLP-1 receptor agonists like Semaglutide and Tirzepatide have been shown to promote weight loss, and this has made them popular in treating obesity, even for those without diabetes.

• Appetite Regulation: GLP-1 agonists help increase feelings of fullness (satiety) and reduce hunger. This makes it easier for individuals to eat less without feeling deprived.
• Decreased Caloric Intake: As a result of reduced appetite, people may consume fewer calories, leading to weight loss.
• Fat Loss: Some studies suggest that GLP-1s may specifically help reduce visceral fat (fat around internal organs), which is linked to a higher risk of metabolic diseases.

Several GLP-1 receptor agonists have shown evidence of improving heart health, especially in people with diabetes or obesity.

• Reduced Risk of Cardiovascular Events: Some medications (e.g., semaglutide and liraglutide) have been shown to reduce the risk of major cardiovascular events like heart attacks, strokes, and cardiovascular death in patients with type 2 diabetes.
• Lower Blood Pressure and Cholesterol: GLP-1s can have a modest effect on lowering blood pressure and improving lipid profiles, such as reducing LDL (“bad”) cholesterol levels.

If you would like to learn more about GLP-1’s, don’t hesitate to reach out. We would love to help you with your weight loss goals.